NS

Nasreen Sarjula

Active Director Director DIN 08163657
DIN 08163657 First appointment Feb 2019 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Nasreen Sarjula

Data last updated:

Nasreen Sarjula is a Director at Isab Biotec Private Limited (since 2019). The company operates in Professional Services.

DIN 08163657
Primary Designation Director
Industry Professional Services
First Appointment 01 Feb 2019
Oldest Company Age 25 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Isab Biotec Private Limited U01117KL2001PTC014596
Director01 Feb 20192001Active

Board colleagues of Nasreen Sarjula

NameDINCompanyDesignation
Isabul Sherin02670109Isab Biotec Private LimitedDirector
Nabeel Babu08810606Isab Biotec Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Isab Biotec Private Limited
Premium access

Shareholding and investment profile for Nasreen Sarjula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nasreen Sarjula

Nasreen Sarjula currently holds 1 directorship: Isab Biotec Private Limited (Director, since 01 Feb 2019).

Nasreen Sarjula was first appointed on 01 Feb 2019 as Director at Isab Biotec Private Limited.

The current boards of Nasreen Sarjula's companies include Isabul Sherin (Isab Biotec Private Limited), Nabeel Babu (Isab Biotec Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available